Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Apr 2026 and Jul 2026.
- Largest single sale: $2.0M (130,000 shares) of MoonLake Immunotherapeutics on Dec 8, 2025. Filing
- Last sale before this period: Feb 29, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer, Director | Apr 15, 2022 | Jul 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 10, 2026, MoonLake Immunotherapeutics: sold 68,289 shares for $1.4M, under a disclosed plan. 1 filing: 1
- Jul 9, 2026, MoonLake Immunotherapeutics: sold 33,936 shares for $679K, under a disclosed plan. 1 filing: 1
- Jul 1, 2026, MoonLake Immunotherapeutics: sold 47,775 shares for $957K, under a disclosed plan. 1 filing: 1
- Apr 13, 2026, MoonLake Immunotherapeutics: sold 51,873 shares for $946K, no plan disclosed. 1 filing: 1
- Apr 10, 2026, MoonLake Immunotherapeutics: sold 98,127 shares for $1.8M, no plan disclosed. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.